Filtros : "National Institute of Health" Limpar

Filtros



Refine with date range


  • Source: Neurology- Genetics. Unidade: FM

    Subjects: GENES, PROTEÍNAS, DOENÇAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SCHIAVA, Marianela et al. Clinical Classification of Variants in the Valosin-Containing Protein Gene Associated With Multisystem Proteinopathy. Neurology- Genetics, v. 9, n. 5, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/81997. Acesso em: 19 fev. 2026.
    • APA

      Schiava, M., Ikenaga, C., Topf, A., Caballero-avila, M., Chou, T. -F., Li, S., et al. (2023). Clinical Classification of Variants in the Valosin-Containing Protein Gene Associated With Multisystem Proteinopathy. Neurology- Genetics, 9( 5). doi:10.1212/NXG.0000000000200093
    • NLM

      Schiava M, Ikenaga C, Topf A, Caballero-avila M, Chou T-F, Li S, Wang F, Daw J, Stojkovic T, Zanoteli E. Clinical Classification of Variants in the Valosin-Containing Protein Gene Associated With Multisystem Proteinopathy [Internet]. Neurology- Genetics. 2023 ; 9( 5):[citado 2026 fev. 19 ] Available from: https://observatorio.fm.usp.br/handle/OPI/81997
    • Vancouver

      Schiava M, Ikenaga C, Topf A, Caballero-avila M, Chou T-F, Li S, Wang F, Daw J, Stojkovic T, Zanoteli E. Clinical Classification of Variants in the Valosin-Containing Protein Gene Associated With Multisystem Proteinopathy [Internet]. Neurology- Genetics. 2023 ; 9( 5):[citado 2026 fev. 19 ] Available from: https://observatorio.fm.usp.br/handle/OPI/81997
  • Source: Acta neuropathologica. Unidade: FM

    Subjects: DOENÇAS NEURODEGENERATIVAS, CÉREBRO, FENÓTIPOS

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ROEMER, Shanu F et al. Rainwater Charitable Foundation criteria for the neuropathologic diagnosis progressive supranuclear palsy. Acta neuropathologica, v. 144, n. 4, p. 603-614, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00401-022-02479-4. Acesso em: 19 fev. 2026.
    • APA

      Roemer, S. F., Grinberg, L. T., Crary, J. F., Seeley, W. W., Mckee, A. C., Kovacs, G. G., et al. (2022). Rainwater Charitable Foundation criteria for the neuropathologic diagnosis progressive supranuclear palsy. Acta neuropathologica, 144( 4), 603-614. doi:10.1007/s00401-022-02479-4
    • NLM

      Roemer SF, Grinberg LT, Crary JF, Seeley WW, Mckee AC, Kovacs GG, Beach TG, Duyckaerts C, Ferrer IA, Gelpi E. Rainwater Charitable Foundation criteria for the neuropathologic diagnosis progressive supranuclear palsy [Internet]. Acta neuropathologica. 2022 ; 144( 4): 603-614.[citado 2026 fev. 19 ] Available from: https://doi.org/10.1007/s00401-022-02479-4
    • Vancouver

      Roemer SF, Grinberg LT, Crary JF, Seeley WW, Mckee AC, Kovacs GG, Beach TG, Duyckaerts C, Ferrer IA, Gelpi E. Rainwater Charitable Foundation criteria for the neuropathologic diagnosis progressive supranuclear palsy [Internet]. Acta neuropathologica. 2022 ; 144( 4): 603-614.[citado 2026 fev. 19 ] Available from: https://doi.org/10.1007/s00401-022-02479-4
  • Source: American heart journal. Unidade: FM

    Subjects: FÁRMACOS (SISTEMA CARDIOVASCULAR), INFARTO DO MIOCÁRDIO, SÍNDROME CORONARIANA AGUDA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BERWANGER, Otavio e NICOLAU, José Carlos. Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: rationale and design of the ticagrelor in patients with ST-elevation myocardial infarction treated with thrombolysis (TREAT) trial. American heart journal, v. 202, p. 89-96, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2018.02.017. Acesso em: 19 fev. 2026.
    • APA

      Berwanger, O., & Nicolau, J. C. (2018). Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: rationale and design of the ticagrelor in patients with ST-elevation myocardial infarction treated with thrombolysis (TREAT) trial. American heart journal, 202, 89-96. doi:10.1016/j.ahj.2018.02.017
    • NLM

      Berwanger O, Nicolau JC. Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: rationale and design of the ticagrelor in patients with ST-elevation myocardial infarction treated with thrombolysis (TREAT) trial [Internet]. American heart journal. 2018 ; 202 89-96.[citado 2026 fev. 19 ] Available from: https://doi.org/10.1016/j.ahj.2018.02.017
    • Vancouver

      Berwanger O, Nicolau JC. Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: rationale and design of the ticagrelor in patients with ST-elevation myocardial infarction treated with thrombolysis (TREAT) trial [Internet]. American heart journal. 2018 ; 202 89-96.[citado 2026 fev. 19 ] Available from: https://doi.org/10.1016/j.ahj.2018.02.017

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2026